Neal Benowitz, MD
Neal Benowitz has been involved in patient care and conducting research at SFGH since 1973. His research focus is on the human pharmacology of nicotine in relation to pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease. He has also studied the human pharmacolgy and toxicology of cannabis products. He has served on a number of national and international committees addressing issues in tobacco-related diseases and smoking cessation, including several sponsored by the Institute of Medicine. He has served as president of the American Society for Clinical Pharmacology and Therapeutics and the Society for Research on Nicotine and Tobacco. He has authored over 700 publications, including a state-of-the-art review on nicotine addiction in the New England Journal of Medicine in June 2010. He maintains an active clinical practice in cardiology and medical toxicology